Ideal Cardiovascular Health Metrics and Fatal Major Adverse Cardiovascular Events in Hypertensive Patients With Blood Pressure At or Above Target.

IF 3.1 3区 医学 Q2 PERIPHERAL VASCULAR DISEASE American Journal of Hypertension Pub Date : 2025-06-16 DOI:10.1093/ajh/hpaf036
Shanshan Shi, Weihua Chen, Lin Deng, Kaihong Chen, Ying Liao
{"title":"Ideal Cardiovascular Health Metrics and Fatal Major Adverse Cardiovascular Events in Hypertensive Patients With Blood Pressure At or Above Target.","authors":"Shanshan Shi, Weihua Chen, Lin Deng, Kaihong Chen, Ying Liao","doi":"10.1093/ajh/hpaf036","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>High blood pressure (BP) is a major risk factor for cardiovascular disease (CVD) events. The ideal cardiovascular health metrics (ICVHMs) have beneficial effects on the cardiovascular system. The present study examined the association between ICVHMs and the risk of hypertension-related CVD in hypertensive patients across different BP ranges.</p><p><strong>Methods: </strong>Analyses included 31,427 adults from the National Health and Nutrition Examination Survey 2005-2018. The BP target was < 130/80 mm Hg and ICVHMs were defined based on the 2022 American Heart Association Presidential Advisory. Fatal major adverse cardiovascular events (MACE) were the primary outcomes. Cox proportional hazards models were used to calculate the HR and 95% CI for MACE mortality.</p><p><strong>Results: </strong>Among 31,427 participants, hypertensive patients with ≥ 5 ICVHMs did not appear significantly additional risk of MACE mortality compared to participants without hypertension (BP at target: HR, 1.09; 95% CI, 0.72-1.64; BP above target: HR, 0.98; 95% CI, 0.69-1.39). Compared to patients with 0-1 ICVHMs, experiencing ≥ 5 ICVHMs was associated with a lower MACE mortality risk (BP at target: HR, 0.60; 95% CI, 0.36-0.98; BP above target: HR, 0.43; 95% CI, 0.30-0.62). Among hypertensive patients, each increase in the number of ICVHMs was associated with a lower risk of MACE mortality (BP at target: HR, 0.86; 95% CI, 0.76-0.97; BP above target: HR, 0.84; 95% CI, 0.78-0.91), even in patients with high-risk factors for CVD.</p><p><strong>Conclusions: </strong>Compared to participants without hypertension, hypertensive patients with fewer ICVHMs, regardless of whether their blood pressure is well-controlled, face a significantly higher risk of MACE mortality.</p>","PeriodicalId":7578,"journal":{"name":"American Journal of Hypertension","volume":" ","pages":"498-508"},"PeriodicalIF":3.1000,"publicationDate":"2025-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Hypertension","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ajh/hpaf036","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0

Abstract

Background: High blood pressure (BP) is a major risk factor for cardiovascular disease (CVD) events. The ideal cardiovascular health metrics (ICVHMs) have beneficial effects on the cardiovascular system. The present study examined the association between ICVHMs and the risk of hypertension-related CVD in hypertensive patients across different BP ranges.

Methods: Analyses included 31,427 adults from the National Health and Nutrition Examination Survey 2005-2018. The BP target was < 130/80 mm Hg and ICVHMs were defined based on the 2022 American Heart Association Presidential Advisory. Fatal major adverse cardiovascular events (MACE) were the primary outcomes. Cox proportional hazards models were used to calculate the HR and 95% CI for MACE mortality.

Results: Among 31,427 participants, hypertensive patients with ≥ 5 ICVHMs did not appear significantly additional risk of MACE mortality compared to participants without hypertension (BP at target: HR, 1.09; 95% CI, 0.72-1.64; BP above target: HR, 0.98; 95% CI, 0.69-1.39). Compared to patients with 0-1 ICVHMs, experiencing ≥ 5 ICVHMs was associated with a lower MACE mortality risk (BP at target: HR, 0.60; 95% CI, 0.36-0.98; BP above target: HR, 0.43; 95% CI, 0.30-0.62). Among hypertensive patients, each increase in the number of ICVHMs was associated with a lower risk of MACE mortality (BP at target: HR, 0.86; 95% CI, 0.76-0.97; BP above target: HR, 0.84; 95% CI, 0.78-0.91), even in patients with high-risk factors for CVD.

Conclusions: Compared to participants without hypertension, hypertensive patients with fewer ICVHMs, regardless of whether their blood pressure is well-controlled, face a significantly higher risk of MACE mortality.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
血压达到或高于目标值的高血压患者的理想心血管健康指标和致命的主要心血管不良事件
背景:高血压(BP)是心血管疾病(CVD)事件的主要危险因素。理想的心血管健康指标(icvhm)对心血管系统有有益的影响。本研究探讨了不同血压范围的高血压患者icvhm与高血压相关心血管疾病风险之间的关系。方法:分析了2005-2018年全国健康与营养检查调查的31427名成年人。结果:在31427名参与者中,与没有高血压的参与者相比,icvhm≥5的高血压患者的MACE死亡风险没有明显增加(目标血压:HR, 1.09;95%置信区间,0.72 - -1.64;BP高于目标:HR, 0.98;95%可信区间,0.69 - -1.39)。与0-1次icvhm患者相比,经历≥5次icvhm的患者与较低的MACE死亡风险相关(目标血压:HR, 0.60;95%置信区间,0.36 - -0.98;BP高于目标:HR, 0.43;95%可信区间,0.30 - -0.62)。在高血压患者中,icvhm数量的增加与MACE死亡风险的降低相关(目标血压:HR, 0.86;95%置信区间,0.76 - -0.97;BP高于目标:HR, 0.84;95%CI, 0.78-0.91),即使在心血管疾病高危因素的患者中也是如此。结论:与无高血压的参与者相比,icvhm较少的高血压患者,无论其血压控制是否良好,其MACE死亡率风险均显着增加。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
American Journal of Hypertension
American Journal of Hypertension 医学-外周血管病
CiteScore
6.90
自引率
6.20%
发文量
144
审稿时长
3-8 weeks
期刊介绍: The American Journal of Hypertension is a monthly, peer-reviewed journal that provides a forum for scientific inquiry of the highest standards in the field of hypertension and related cardiovascular disease. The journal publishes high-quality original research and review articles on basic sciences, molecular biology, clinical and experimental hypertension, cardiology, epidemiology, pediatric hypertension, endocrinology, neurophysiology, and nephrology.
期刊最新文献
Reducing Clinical Inertia in Hypertension Through Primary Care Practitioner-Led Remote Patient Monitoring. Trends in Initial Combination Antihypertensive Therapy in a US Health System. Restless Legs, Relentless Pressure: The Non-Dipping Pattern in Restless Legs Syndrome Beyond Shared Comorbidities. Association of Non-Insulin-Based Markers of Insulin Resistance with Hypertension in Type 2 Diabetes: An Age- and Gender-Matched Cross-Sectional Study. Hypertension Medication Changes in Patients Prescribed Remote Monitoring.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1